Advertisement
active pharma ingredients
Healthcare
17 August, 2022
Rakesh Jhunjhunwala firm-backed Concord Biotech files for IPO
Late billionaire investor Rakesh Jhunjhunwala's firm Rare Enterprises-backed Concord Biotech has filed its draft red herring prospectus (DRHP) with capital ......